img

Global Targeted Radionuclide Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Targeted Radionuclide Therapy Market Insights, Forecast to 2034

Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.
Market Analysis and InsightsGlobal Targeted Radionuclide Therapy Market
Global Targeted Radionuclide Therapy market is expected to reach to US$ 1708 million in 2024, with a positive growth of %, compared with US$ 1043 million in 2022. Backed with the increasing demand from downstream industries, Targeted Radionuclide Therapy industry is evaluated to reach US$ 4471.9 million in 2029. The CAGR will be 17.4% during 2024 to 2029.
The key drivers of the radioimmunotherapy market is its potential to deliver highly targeted and precise treatment to cancer cells, sparing healthy tissues and reducing side effects compared to traditional radiation therapies. The ability of RIT to offer personalized treatment options based on specific cancer biomarkers further enhances its appeal in the field of precision medicine. However, the radioimmunotherapy market also faces challenges. One major challenge is the high cost associated with the development and production of radiopharmaceuticals, limiting access for some patients and healthcare systems. Additionally, navigating complex regulatory pathways for approval and reimbursement of RIT products can be time-consuming and resource-intensive for pharmaceutical companies. Furthermore, there may be limited awareness and acceptance of RIT among healthcare professionals and patients, leading to slower adoption rates and market penetration. Addressing these challenges requires continued research and investment in RIT technologies to improve efficacy and cost-effectiveness. Collaborations between pharmaceutical companies, research institutions, and healthcare organizations can facilitate knowledge-sharing and streamline the regulatory process.
Report Covers
This report presents an overview of global Targeted Radionuclide Therapy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Targeted Radionuclide Therapy market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Curium Pharmaceuticals
Gilead Sciences
Clarity Pharmaceuticals
Curasight
Nordic Nanovector
Philogen
RadioMedix
Telix Pharmaceuticals
Orano Med
Actinium Pharmaceuticals
Y-mAbs Therapeutics
Fusion Pharmaceuticals
Segment by Type
Beta-emitting
Targeted Alpha Therapy

Segment by Application


Solid Tumor
Non Hodgkin Lymphoma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Targeted Radionuclide Therapy introduction, etc. Targeted Radionuclide Therapy Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Targeted Radionuclide Therapy
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Radionuclide Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Beta-emitting
1.2.3 Targeted Alpha Therapy
1.3 Market by Application
1.3.1 Global Targeted Radionuclide Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Solid Tumor
1.3.3 Non Hodgkin Lymphoma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Radionuclide Therapy Market Perspective (2018-2029)
2.2 Global Targeted Radionuclide Therapy Growth Trends by Region
2.2.1 Targeted Radionuclide Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Targeted Radionuclide Therapy Historic Market Size by Region (2018-2024)
2.2.3 Targeted Radionuclide Therapy Forecasted Market Size by Region (2024-2029)
2.3 Targeted Radionuclide Therapy Market Dynamics
2.3.1 Targeted Radionuclide Therapy Industry Trends
2.3.2 Targeted Radionuclide Therapy Market Drivers
2.3.3 Targeted Radionuclide Therapy Market Challenges
2.3.4 Targeted Radionuclide Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Targeted Radionuclide Therapy by Players
3.1.1 Global Targeted Radionuclide Therapy Revenue by Players (2018-2024)
3.1.2 Global Targeted Radionuclide Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Targeted Radionuclide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Targeted Radionuclide Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Targeted Radionuclide Therapy Market Concentration Ratio
3.4.1 Global Targeted Radionuclide Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Radionuclide Therapy Revenue in 2022
3.5 Global Key Players of Targeted Radionuclide Therapy Head office and Area Served
3.6 Global Key Players of Targeted Radionuclide Therapy, Product and Application
3.7 Global Key Players of Targeted Radionuclide Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Radionuclide Therapy Breakdown Data by Type
4.1 Global Targeted Radionuclide Therapy Historic Market Size by Type (2018-2024)
4.2 Global Targeted Radionuclide Therapy Forecasted Market Size by Type (2024-2029)
5 Targeted Radionuclide Therapy Breakdown Data by Application
5.1 Global Targeted Radionuclide Therapy Historic Market Size by Application (2018-2024)
5.2 Global Targeted Radionuclide Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Targeted Radionuclide Therapy Market Size (2018-2029)
6.2 North America Targeted Radionuclide Therapy Market Size by Type
6.2.1 North America Targeted Radionuclide Therapy Market Size by Type (2018-2024)
6.2.2 North America Targeted Radionuclide Therapy Market Size by Type (2024-2029)
6.2.3 North America Targeted Radionuclide Therapy Market Share by Type (2018-2029)
6.3 North America Targeted Radionuclide Therapy Market Size by Application
6.3.1 North America Targeted Radionuclide Therapy Market Size by Application (2018-2024)
6.3.2 North America Targeted Radionuclide Therapy Market Size by Application (2024-2029)
6.3.3 North America Targeted Radionuclide Therapy Market Share by Application (2018-2029)
6.4 North America Targeted Radionuclide Therapy Market Size by Country
6.4.1 North America Targeted Radionuclide Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Targeted Radionuclide Therapy Market Size by Country (2018-2024)
6.4.3 North America Targeted Radionuclide Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Targeted Radionuclide Therapy Market Size (2018-2029)
7.2 Europe Targeted Radionuclide Therapy Market Size by Type
7.2.1 Europe Targeted Radionuclide Therapy Market Size by Type (2018-2024)
7.2.2 Europe Targeted Radionuclide Therapy Market Size by Type (2024-2029)
7.2.3 Europe Targeted Radionuclide Therapy Market Share by Type (2018-2029)
7.3 Europe Targeted Radionuclide Therapy Market Size by Application
7.3.1 Europe Targeted Radionuclide Therapy Market Size by Application (2018-2024)
7.3.2 Europe Targeted Radionuclide Therapy Market Size by Application (2024-2029)
7.3.3 Europe Targeted Radionuclide Therapy Market Share by Application (2018-2029)
7.4 Europe Targeted Radionuclide Therapy Market Size by Country
7.4.1 Europe Targeted Radionuclide Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Targeted Radionuclide Therapy Market Size by Country (2018-2024)
7.4.3 Europe Targeted Radionuclide Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Targeted Radionuclide Therapy Market Size (2018-2029)
8.2 China Targeted Radionuclide Therapy Market Size by Type
8.2.1 China Targeted Radionuclide Therapy Market Size by Type (2018-2024)
8.2.2 China Targeted Radionuclide Therapy Market Size by Type (2024-2029)
8.2.3 China Targeted Radionuclide Therapy Market Share by Type (2018-2029)
8.3 China Targeted Radionuclide Therapy Market Size by Application
8.3.1 China Targeted Radionuclide Therapy Market Size by Application (2018-2024)
8.3.2 China Targeted Radionuclide Therapy Market Size by Application (2024-2029)
8.3.3 China Targeted Radionuclide Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Targeted Radionuclide Therapy Market Size (2018-2029)
9.2 Asia Targeted Radionuclide Therapy Market Size by Type
9.2.1 Asia Targeted Radionuclide Therapy Market Size by Type (2018-2024)
9.2.2 Asia Targeted Radionuclide Therapy Market Size by Type (2024-2029)
9.2.3 Asia Targeted Radionuclide Therapy Market Share by Type (2018-2029)
9.3 Asia Targeted Radionuclide Therapy Market Size by Application
9.3.1 Asia Targeted Radionuclide Therapy Market Size by Application (2018-2024)
9.3.2 Asia Targeted Radionuclide Therapy Market Size by Application (2024-2029)
9.3.3 Asia Targeted Radionuclide Therapy Market Share by Application (2018-2029)
9.4 Asia Targeted Radionuclide Therapy Market Size by Region
9.4.1 Asia Targeted Radionuclide Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Targeted Radionuclide Therapy Market Size by Region (2018-2024)
9.4.3 Asia Targeted Radionuclide Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Targeted Radionuclide Therapy Introduction
11.1.4 Bayer Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.1.5 Bayer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Targeted Radionuclide Therapy Introduction
11.2.4 Novartis Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 Lantheus
11.3.1 Lantheus Company Details
11.3.2 Lantheus Business Overview
11.3.3 Lantheus Targeted Radionuclide Therapy Introduction
11.3.4 Lantheus Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.3.5 Lantheus Recent Developments
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Details
11.4.2 Aurobindo Pharma Business Overview
11.4.3 Aurobindo Pharma Targeted Radionuclide Therapy Introduction
11.4.4 Aurobindo Pharma Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.4.5 Aurobindo Pharma Recent Developments
11.5 Mundipharma
11.5.1 Mundipharma Company Details
11.5.2 Mundipharma Business Overview
11.5.3 Mundipharma Targeted Radionuclide Therapy Introduction
11.5.4 Mundipharma Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.5.5 Mundipharma Recent Developments
11.6 China Isotope & Radiation
11.6.1 China Isotope & Radiation Company Details
11.6.2 China Isotope & Radiation Business Overview
11.6.3 China Isotope & Radiation Targeted Radionuclide Therapy Introduction
11.6.4 China Isotope & Radiation Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.6.5 China Isotope & Radiation Recent Developments
11.7 Curium Pharmaceuticals
11.7.1 Curium Pharmaceuticals Company Details
11.7.2 Curium Pharmaceuticals Business Overview
11.7.3 Curium Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.7.4 Curium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.7.5 Curium Pharmaceuticals Recent Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Targeted Radionuclide Therapy Introduction
11.8.4 Gilead Sciences Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.8.5 Gilead Sciences Recent Developments
11.9 Clarity Pharmaceuticals
11.9.1 Clarity Pharmaceuticals Company Details
11.9.2 Clarity Pharmaceuticals Business Overview
11.9.3 Clarity Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.9.4 Clarity Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.9.5 Clarity Pharmaceuticals Recent Developments
11.10 Curasight
11.10.1 Curasight Company Details
11.10.2 Curasight Business Overview
11.10.3 Curasight Targeted Radionuclide Therapy Introduction
11.10.4 Curasight Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.10.5 Curasight Recent Developments
11.11 Nordic Nanovector
11.11.1 Nordic Nanovector Company Details
11.11.2 Nordic Nanovector Business Overview
11.11.3 Nordic Nanovector Targeted Radionuclide Therapy Introduction
11.11.4 Nordic Nanovector Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.11.5 Nordic Nanovector Recent Developments
11.12 Philogen
11.12.1 Philogen Company Details
11.12.2 Philogen Business Overview
11.12.3 Philogen Targeted Radionuclide Therapy Introduction
11.12.4 Philogen Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.12.5 Philogen Recent Developments
11.13 RadioMedix
11.13.1 RadioMedix Company Details
11.13.2 RadioMedix Business Overview
11.13.3 RadioMedix Targeted Radionuclide Therapy Introduction
11.13.4 RadioMedix Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.13.5 RadioMedix Recent Developments
11.14 Telix Pharmaceuticals
11.14.1 Telix Pharmaceuticals Company Details
11.14.2 Telix Pharmaceuticals Business Overview
11.14.3 Telix Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.14.4 Telix Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.14.5 Telix Pharmaceuticals Recent Developments
11.15 Orano Med
11.15.1 Orano Med Company Details
11.15.2 Orano Med Business Overview
11.15.3 Orano Med Targeted Radionuclide Therapy Introduction
11.15.4 Orano Med Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.15.5 Orano Med Recent Developments
11.16 Actinium Pharmaceuticals
11.16.1 Actinium Pharmaceuticals Company Details
11.16.2 Actinium Pharmaceuticals Business Overview
11.16.3 Actinium Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.16.4 Actinium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.16.5 Actinium Pharmaceuticals Recent Developments
11.17 Y-mAbs Therapeutics
11.17.1 Y-mAbs Therapeutics Company Details
11.17.2 Y-mAbs Therapeutics Business Overview
11.17.3 Y-mAbs Therapeutics Targeted Radionuclide Therapy Introduction
11.17.4 Y-mAbs Therapeutics Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.17.5 Y-mAbs Therapeutics Recent Developments
11.18 Fusion Pharmaceuticals
11.18.1 Fusion Pharmaceuticals Company Details
11.18.2 Fusion Pharmaceuticals Business Overview
11.18.3 Fusion Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.18.4 Fusion Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.18.5 Fusion Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Targeted Radionuclide Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Beta-emitting
Table 3. Key Players of Targeted Alpha Therapy
Table 4. Global Targeted Radionuclide Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Targeted Radionuclide Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Targeted Radionuclide Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Targeted Radionuclide Therapy Market Share by Region (2018-2024)
Table 8. Global Targeted Radionuclide Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Targeted Radionuclide Therapy Market Share by Region (2024-2029)
Table 10. Targeted Radionuclide Therapy Market Trends
Table 11. Targeted Radionuclide Therapy Market Drivers
Table 12. Targeted Radionuclide Therapy Market Challenges
Table 13. Targeted Radionuclide Therapy Market Restraints
Table 14. Global Targeted Radionuclide Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Targeted Radionuclide Therapy Revenue Share by Players (2018-2024)
Table 16. Global Top Targeted Radionuclide Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Therapy as of 2022)
Table 17. Global Targeted Radionuclide Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Targeted Radionuclide Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Targeted Radionuclide Therapy, Headquarters and Area Served
Table 20. Global Key Players of Targeted Radionuclide Therapy, Product and Application
Table 21. Global Key Players of Targeted Radionuclide Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Targeted Radionuclide Therapy Revenue Market Share by Type (2018-2024)
Table 25. Global Targeted Radionuclide Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Targeted Radionuclide Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Targeted Radionuclide Therapy Revenue Share by Application (2018-2024)
Table 29. Global Targeted Radionuclide Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Targeted Radionuclide Therapy Revenue Share by Application (2024-2029)
Table 31. North America Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Targeted Radionuclide Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Targeted Radionuclide Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Targeted Radionuclide Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Targeted Radionuclide Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Targeted Radionuclide Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Targeted Radionuclide Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Targeted Radionuclide Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Targeted Radionuclide Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Targeted Radionuclide Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Targeted Radionuclide Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Targeted Radionuclide Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Targeted Radionuclide Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Targeted Radionuclide Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Targeted Radionuclide Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Targeted Radionuclide Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Targeted Radionuclide Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Targeted Radionuclide Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Targeted Radionuclide Therapy Product
Table 66. Bayer Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 67. Bayer Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Targeted Radionuclide Therapy Product
Table 71. Novartis Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Lantheus Company Details
Table 74. Lantheus Business Overview
Table 75. Lantheus Targeted Radionuclide Therapy Product
Table 76. Lantheus Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 77. Lantheus Recent Developments
Table 78. Aurobindo Pharma Company Details
Table 79. Aurobindo Pharma Business Overview
Table 80. Aurobindo Pharma Targeted Radionuclide Therapy Product
Table 81. Aurobindo Pharma Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 82. Aurobindo Pharma Recent Developments
Table 83. Mundipharma Company Details
Table 84. Mundipharma Business Overview
Table 85. Mundipharma Targeted Radionuclide Therapy Product
Table 86. Mundipharma Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 87. Mundipharma Recent Developments
Table 88. China Isotope & Radiation Company Details
Table 89. China Isotope & Radiation Business Overview
Table 90. China Isotope & Radiation Targeted Radionuclide Therapy Product
Table 91. China Isotope & Radiation Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 92. China Isotope & Radiation Recent Developments
Table 93. Curium Pharmaceuticals Company Details
Table 94. Curium Pharmaceuticals Business Overview
Table 95. Curium Pharmaceuticals Targeted Radionuclide Therapy Product
Table 96. Curium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 97. Curium Pharmaceuticals Recent Developments
Table 98. Gilead Sciences Company Details
Table 99. Gilead Sciences Business Overview
Table 100. Gilead Sciences Targeted Radionuclide Therapy Product
Table 101. Gilead Sciences Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 102. Gilead Sciences Recent Developments
Table 103. Clarity Pharmaceuticals Company Details
Table 104. Clarity Pharmaceuticals Business Overview
Table 105. Clarity Pharmaceuticals Targeted Radionuclide Therapy Product
Table 106. Clarity Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 107. Clarity Pharmaceuticals Recent Developments
Table 108. Curasight Company Details
Table 109. Curasight Business Overview
Table 110. Curasight Targeted Radionuclide Therapy Product
Table 111. Curasight Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 112. Curasight Recent Developments
Table 113. Nordic Nanovector Company Details
Table 114. Nordic Nanovector Business Overview
Table 115. Nordic Nanovector Targeted Radionuclide Therapy Product
Table 116. Nordic Nanovector Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 117. Nordic Nanovector Recent Developments
Table 118. Philogen Company Details
Table 119. Philogen Business Overview
Table 120. Philogen Targeted Radionuclide Therapy Product
Table 121. Philogen Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 122. Philogen Recent Developments
Table 123. RadioMedix Company Details
Table 124. RadioMedix Business Overview
Table 125. RadioMedix Targeted Radionuclide Therapy Product
Table 126. RadioMedix Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 127. RadioMedix Recent Developments
Table 128. Telix Pharmaceuticals Company Details
Table 129. Telix Pharmaceuticals Business Overview
Table 130. Telix Pharmaceuticals Targeted Radionuclide Therapy Product
Table 131. Telix Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 132. Telix Pharmaceuticals Recent Developments
Table 133. Orano Med Company Details
Table 134. Orano Med Business Overview
Table 135. Orano Med Targeted Radionuclide Therapy Product
Table 136. Orano Med Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 137. Orano Med Recent Developments
Table 138. Actinium Pharmaceuticals Company Details
Table 139. Actinium Pharmaceuticals Business Overview
Table 140. Actinium Pharmaceuticals Targeted Radionuclide Therapy Product
Table 141. Actinium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 142. Actinium Pharmaceuticals Recent Developments
Table 143. Y-mAbs Therapeutics Company Details
Table 144. Y-mAbs Therapeutics Business Overview
Table 145. Y-mAbs Therapeutics Targeted Radionuclide Therapy Product
Table 146. Y-mAbs Therapeutics Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 147. Y-mAbs Therapeutics Recent Developments
Table 148. Fusion Pharmaceuticals Company Details
Table 149. Fusion Pharmaceuticals Business Overview
Table 150. Fusion Pharmaceuticals Targeted Radionuclide Therapy Product
Table 151. Fusion Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 152. Fusion Pharmaceuticals Recent Developments
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Radionuclide Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Targeted Radionuclide Therapy Market Share by Type: 2022 VS 2029
Figure 3. Beta-emitting Features
Figure 4. Targeted Alpha Therapy Features
Figure 5. Global Targeted Radionuclide Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Targeted Radionuclide Therapy Market Share by Application: 2022 VS 2029
Figure 7. Solid Tumor Case Studies
Figure 8. Non Hodgkin Lymphoma Case Studies
Figure 9. Targeted Radionuclide Therapy Report Years Considered
Figure 10. Global Targeted Radionuclide Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Targeted Radionuclide Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Targeted Radionuclide Therapy Market Share by Region: 2022 VS 2029
Figure 13. Global Targeted Radionuclide Therapy Market Share by Players in 2022
Figure 14. Global Top Targeted Radionuclide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Therapy as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Targeted Radionuclide Therapy Revenue in 2022
Figure 16. North America Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 18. North America Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 19. North America Targeted Radionuclide Therapy Market Share by Country (2018-2029)
Figure 20. United States Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Targeted Radionuclide Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 24. Europe Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 25. Europe Targeted Radionuclide Therapy Market Share by Country (2018-2029)
Figure 26. Germany Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China Targeted Radionuclide Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 34. China Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 35. Asia Targeted Radionuclide Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 37. Asia Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 38. Asia Targeted Radionuclide Therapy Market Share by Region (2018-2029)
Figure 39. Japan Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America Targeted Radionuclide Therapy Market Share by Country (2018-2029)
Figure 49. Brazil Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Bayer Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 56. Novartis Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 57. Lantheus Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 58. Aurobindo Pharma Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 59. Mundipharma Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 60. China Isotope & Radiation Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 61. Curium Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 62. Gilead Sciences Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 63. Clarity Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 64. Curasight Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 65. Nordic Nanovector Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 66. Philogen Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 67. RadioMedix Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 68. Telix Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 69. Orano Med Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 70. Actinium Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 71. Y-mAbs Therapeutics Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 72. Fusion Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries